1000 IU Recombinant Human Erythropoietin Injection IP

Name: 1000 IU Recombinant Human Erythropoietin Injection IP
Brand: NEETCO BIOPHARMA
Price: 171 INR
Availability: InStock

Price 171 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

1000 IU Recombinant Human Erythropoietin Injection IP Specification

HS Code
3002

Molecular Formula
C815H1317N233O241S5

Appearance
Clear, colorless liquid

Dosage Guidelines
As directed by the physician

Purity
>99% (by SDS-PAGE)

Pacakaging (Quantity Per Box)
1 pre-filled syringe of 1 ml

Solubility
Soluble in aqueous solutions

Assay
Meets Pharmacopoeial Standards

Melting Point
Not applicable (biological liquid)

Suitable For
Adults

CAS No
113427-24-0

Physical Form
Injection

Type
Recombinant protein

Ingredients
Recombinant Human Erythropoietin alpha, buffer solution

Feature
1000 IU Erythropoietin alpha per ml

Shelf Life
24 Months

Storage Instructions
Store at 2C to 8C. Do not freeze.

Administration Route
Subcutaneous or intravenous injection

Prescription/Non Prescription
Prescription

Brand Name
As per pack/supplier

Indication
Treatment of anemia associated with chronic renal failure, chemotherapy, and other causes

Strength
1000 IU/ml

Precautions
Monitor hemoglobin regularly; use under medical supervision

Inactive Ingredients
Polysorbate 20, sodium chloride, sodium phosphate, citric acid, water for injection

Disposal
Dispose of used syringes in a sharps container as per biomedical waste norms

Common Side Effects
Hypertension, injection site pain, headache

Container Type
Pre-filled syringe

Pharmacopoeia Standard
IP (Indian Pharmacopoeia)

Contraindications
Uncontrolled hypertension, hypersensitivity to EPO

About 1000 IU Recombinant Human Erythropoietin Injection IP

1000 IU Recombinant Human Erythropoietin Injection IP emerges as a paragon in the management of anemia, championing favorable reviews among physicians and patients. With a fresh, clear appearance and impeccable purity exceeding 99%, this latest formulation contains 1000 IU/ml Erythropoietin alpha, supplied in a convenient pre-filled syringe. Suitable for adults and indicated for treating anemia associated with chronic renal failure, chemotherapy, and other origins, it delivers consistent efficacy. Developed to Indian Pharmacopoeia standards, it is administered either subcutaneously or intravenously, ensuring optimal absorption and reliable results. Strictly for prescription use, it is designed for safe handling and monitored dosing.

Precise Application and Usage Information

1000 IU Recombinant Human Erythropoietin Injection IP is administered subcutaneously or intravenously, depending on physician directives. The application surface is the skin or a vein, and it is used as a therapeutic agent for treating anemia, particularly in adults dealing with chronic renal failure or undergoing chemotherapy. Its clear, colorless liquid form allows for easy observation during preparation and administration, ensuring accuracy and safety for every dose provided in the pre-filled syringe.

Flexible Payment and Global Supply Terms

Buyers can inquire about the asking price or negotiate the sale price for 1000 IU Recombinant Human Erythropoietin Injection IP. The product is readily exportable to major markets worldwide, including India and beyond, with express shipping options available for swift delivery. With strong supply ability and reliable distribution channels, each order contains one pre-filled syringe per box. Flexible payment terms are available for distributors, exporters, and suppliers, meeting the demands of global partners.

FAQ's of 1000 IU Recombinant Human Erythropoietin Injection IP:

Q: How should 1000 IU Recombinant Human Erythropoietin Injection IP be administered?

A: It should be administered subcutaneously or intravenously as directed by a healthcare professional. Use only under medical supervision.

Q: What precautions must be taken while using this injection?

A: Regular monitoring of hemoglobin is required, and usage should be strictly supervised by a physician. Avoid administration in patients with uncontrolled hypertension or hypersensitivity to EPO.

Q: When is 1000 IU Recombinant Human Erythropoietin Injection IP indicated?

A: It is indicated for the treatment of anemia associated with chronic renal failure, chemotherapy, or other causes, based on a doctor's evaluation.

Q: Where should used syringes of this product be disposed of?

A: Dispose of used syringes in a designated sharps container according to biomedical waste management regulations.

Q: What are the common side effects associated with this injection?

A: Common side effects can include hypertension, injection site pain, and headache. Contact your healthcare provider if you experience any unusual symptoms.